What’s wrong with hannah

Embed Size (px)

Citation preview

Whats wrong with Hannah?McKenzi Shelton

Case studyHannah Avromovitch just had her first birthday. She was brought in to the clinic with mental-motor deterioration, convulsions, and hypotonia. Her parents say this began very recently.

What is your initial diagnosis?

What tests do you perform to confirm your diagnosis?Upon examination it was found that Hannah's eye has a retinal cherry red spot

What questions do you ask her parents?

Background informationHannahs family is Ashkenazi Jewish

Hannahs parents are first cousins

The Avromovitches have had two children that died a few years after experiencing these symptoms in infancy

diagnosisHannah has Tay-Sachs disease

Also called GM2 gangliosidosis I

Infants become nonresponsive to stimulation, suffer from seizures, various forms of motor and neuron degradation, and ultimately death

Caused by a mutation in the HEXA gene

Encodes alpha subunit of beta-hexosaminidase

Produces ganglioside accumulation in lysosomes (neurons)

Destructive

Carriers can be identified by an enzyme assay (blood test)Measures level of Hex-A in blood

Carriers have low levels of Hex-A

Biochemistry of tay-sachsInability to properly degrade beta-hexosaminidase

Beta-hexosaminidase

Enzyme

Dimer

Alpha and beta subunits

Normally, a GM2 activator protein binds tgo GM2 gangliosides and hexosaminidase before digestion of the sphingolipids occurs

If the sphingolipids are not digested the lysosomes become engorged and eventually choke off needed cellular functions

Structures HexA and GM2 activator on GM2 gangliosides

Crystalline structure of human beta-Hexosaminidase A

Do you know someone, including yourself, that has tay-sachs?

Occurrence of tay-sachsHigh incidence in Ashkenazi Jews

Three mutations that are present in high frequency

Both parents must be carriers 1 in 250 of US population is a carrier

1 in 50 Irish Americans are carriers

Treatments There is no cure

Symptomatic treatment given

Enzyme replacement and gene therapies under trial

Sourceshttps://www.ncbi.nlm.nih.gov/pubmed/7732608

http://www.namrata.co/case-study-taysachs-disease/

http://chemistry.gravitywaves.com/chemistry/faculty/nsturm/CHE452/14_Biochem%20of%20Disease.htm

https://www.ncbi.nlm.nih.gov/pubmed/1834320

http://themedicalbiochemistrypage.org/taysachsdisease.php

http://019221f.netsolhost.com/carrierstats.shtml